Atrial fibrillation is a cardiac arrhythmia of high prevalence in the population, especially in the elderly. Its main electrical characteristics are the interval between two successive irregular R waves, absence of P waves and presence of f waves between QRS complexes. The most common symptoms of atrial fibrillation are irregular palpitations associated with dyspnea, dizziness, feeling tired, fatigue and general malaise, but not all patients have any symptoms. The present report presents the history of an elderly patient who arrived at the hospital’s emergency department with irregular heart rhythm and palpitations. The patient’s symptoms, associated with the electrocardiogram results, indicated paroxysmal atrial fibrillation. Electrical cardioversion was performed, and after, cardiac ablation via the femoral vein at the hospital’s cardiology service. There were no complications during the procedure. As a routine imaging exam after ablation, control esophagogastroduodenoscopy was requested to verify that there was no formation of atrio-esophageal fistula developed by the invasive ablation procedure and electrocardiogram, which showed normal sinus rhythm. The patient remained in the cardiac intensive care unit for observation for 24 hours. After the electrical cardioversion and catheter ablation procedures, the patient improved his clinical picture of atrial fibrillation and was discharged after 24 hours of hospitalization. He received treatment to perform at home, to reduce acid reflux into the esophagus and to prevent thrombosis. He did not present pulmonary thromboembolism after hospital discharge. It is believed, therefore, that this form of treatment and management of paroxysmal atrial fibrillation is effective for the solution of the proposed problem and can also serve as a reference for other professionals within the cardiology service.
References
[1]
Cuculich, P. and Kates, A. (2014) Manual Washington de especialidades clínicas-Cardiología. 3a edicion, Wolters Kluwer Pvt Ltd., Barcelona, Espana, 468.
[2]
Go, A., Hylek, E. and Phillips, K. (2001) Prevalence of Diagnosed Atrial Fibrillation in Adults and National Implications for Rhythm Management and Stroke Prevention: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. The Journal of the American Medical Association, 285, 2370-2375.
https://jamanetwork.com/journals/jama/fullarticle/193807
https://doi.org/10.1001/jama.285.18.2370
[3]
Calkins, H., Hindricks, G., Cappato, R., et al. (2017) 2017 HRS/EHRA/ECAS/ APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm, 14, 275-444.
https://www.ncbi.nlm.nih.gov/pubmed/28506916
https://doi.org/10.1016/j.hrthm.2017.05.012
[4]
Hakalahti, A., Biancari, F., Nielsen, J.C., et al. (2015) Radiofrequency Ablation vs. Antiarrhythmic Drug Therapy as First Line Treatment of Symptomatic Atrial Fibrillation: Systematic Review and Meta-Analysis. Europace, 17, 370-378.
https://www.ncbi.nlm.nih.gov/pubmed/25643988
https://doi.org/10.1093/europace/euu376
[5]
Chugh, S., Blackshear, J., Shen, W., et al. (2001) Epidemiology and Natural History of Atrial Fibrillation: Clinical Implications. Journal of the American College of Cardiology, 37, 371-378. https://www.ncbi.nlm.nih.gov/pubmed/11216949
https://doi.org/10.1016/S0735-1097(00)01107-4
[6]
Fukui, A., Tanino, T., Yamaguchi, T., et al. (2020) Catheter Ablation of Atrial Fibrillation Reduces Heart Failure Rehospitalization in Patients with Heart Failure with Preserved Ejection Fraction. Journal of Cardiovascular Electrophysiology, 31, 682-688.
https://www.ncbi.nlm.nih.gov/pubmed/31985099
https://doi.org/10.1111/jce.14369
[7]
Friberg, L. and Bergfeldt, L. (2013) Atrial Fibrillation Prevalence Revisited. Journal of Internal Medicine, 274, 461-468.
https://www.ncbi.nlm.nih.gov/pubmed/23879838
https://doi.org/10.1111/joim.12114
[8]
Capucci, A. and Compagnucci, P. (2020) Is Delayed Cardioversion the Better Approach in Recent-Onset Atrial Fibrillation? No. International Journal of Internal and Emergency Medicine, 15, 5-7. https://www.ncbi.nlm.nih.gov/pubmed/31721018
https://doi.org/10.1007/s11739-019-02224-y
[9]
Odozynski, G., Dal Forno, A., Lewandowski, A., et al. (2018) Ablacao de fibrilacao atrial paroxística em mulheres: Compreendendo a diferenca entre os gêneros. Arquivos Brasileiros de Cardiologia, 110, 55-57.
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2018000500449&lng=pt&nrm=iso&tlng=pt
[10]
January, C., Wann, L., Alpert, J., et al. (2014) 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Journal of the American Heart Association, 130, 199-267. https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000000041
https://doi.org/10.1161/CIR.0000000000000041
[11]
Loungani, R., Rehorn, M., Geurink, K., et al. (2020) Outcomes Following Cardioversion for Patients with Cardiac Amyloidosis and Atrial Fibrillation or Atrial Flutter. American Heart Journal, 222, 26-29.
https://www.ncbi.nlm.nih.gov/pubmed/32004797
https://doi.org/10.1016/j.ahj.2020.01.002
[12]
Rodrigues, T. and Miranda, R. (1999) Epidemiology, Etiology and Classification of Atrial Fibrillation. Journal of Cardiac Arrhythmias, 12, 4-11.
http://relampa.org.br/details/263/pt-BR/aspectos-epidemiologicos--etiologia-e-classificacao-da-fibrilacao-atrial
[13]
Huang, B., Liu, H., Scherlag, B., et al. (2020) Atrial Fibrillation in Obstructive Sleep Apnea: Neural Mechanisms and Emerging Therapies. Trends in Cardiovascular Medicine, 5. https://www.ncbi.nlm.nih.gov/pubmed/32008837
https://doi.org/10.1016/j.tcm.2020.01.006
[14]
Magalhaes, L., Figueiredo, M., Cintra, F., et al. (2016) II Diretrizes Brasileiras de Fibrilacao Atrial. Arquivos Brasileiros de Cardiologia, 106, 141-197.
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016003100001
https://doi.org/10.5935/abc.20160055
[15]
Cox, J., Schuessler, R., Lappas, D., et al. (1996) An 81k-Year Clinical Experience with Surgery for Atrial Fibrillation. Annals of Surgery, 224, 267-273.
https://www.ncbi.nlm.nih.gov/pubmed/8813255
https://doi.org/10.1097/00000658-199609000-00003
[16]
Anannab, A., Gianni, C., Della Rocca, D., et al. (2020) Catheter Ablation Is Preferred over Surgery for Persistent Atrial Fibrillation. Journal of Cardiovascular Electrophysiology, 31, 24-29. https://www.ncbi.nlm.nih.gov/pubmed/32293063
https://doi.org/10.1111/jce.14497
[17]
Miura, K., Ikemura, N., Kohsaka, S., et al. (2020) Treatment Strategies and Subsequent Changes in the Patient-Reported Quality-of-Life among Elderly Patients with Atrial Fibrillation. American Heart Journal, 222, 83-92.
https://www.ncbi.nlm.nih.gov/pubmed/32028139
https://doi.org/10.1016/j.ahj.2020.01.011
[18]
Da Silva, R., Arantes, R., Araújo, L., et al. (2018) Incidence of Esophageal Lesions in Patients Undergoing Ablation for Atrial Fibrillation with Multipolar Pulmonary Vein Ablation Catheter (PVAC-GOLDr). Journal of Cardiac Arrhythmias, 31, 71-79.
http://www.relampa.org.br/details/1116/pt-BR/incidencia-de-lesoes-esofagicas-em-pacientes-submetidos-a-ablacao-de-fibrilacao-atrial-com-cateter-circular-multipolar--pvac-goldr-
https://doi.org/10.24207/1983-5558v31.2-004
[19]
Kheiri, B., Barbarawi, M., Zayed, Y., et al. (2019) Antiarrhythmic Drugs or Catheter Ablation in the Management of Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter-Defibrillators. Circulation: Arrhythmia and Electrophysiology-American Heart Association, 12, 41-46.
https://www.ncbi.nlm.nih.gov/pubmed/31698933
https://doi.org/10.1161/CIRCEP.119.007600